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Discrimination against the mentally ill dates back to antiquity. In
classical Greece, people with mental illness were not allowed to
walk the streets of the city, and their families were fined if they
failed to control them.1 In the Middle Ages, many of the mentally
ill were branded as witches2 or ‘treated’ by means of starving,
flogging and chains.1 In the first half of the previous century the
mentally ill in Europe were persecuted and killed by the Nazi
regime.3;4 South Africa has been no different from the rest of the
world in terms of discriminating against psychiatric illness, and in
1846 the prison colony on Robben Island was converted into a
hospital for ‘lepers, lunatics and other chronically ill patients’.5
Although the situation seems to have improved over the last few
decades, stigmatisation of mental illness remains extremely
prevalent, even in so-called developed societies.6;7
Advocacy groups have become increasingly important role
players in the field of mental health, although with mixed success.
Media-supported educational campaigns have done a great deal to
raise the level of public awareness, thereby dispelling old myths
and misconceptions on which the discrimination was based. Also,
as a result of governmental lobbying, some countries have moved
to address the issue of dicriminatory practices against psychiatric
patients. This includes discriminatory health care funding
practices, where benefits for the treatment of psychiatric disorders
are substantially less than those for other illnesses. In the USA,
pressure by these groups led to the introduction of the Mental
Health Parity Act of 1996, which went some way towards reducing
discriminatory funding practices. At the present time, 35 states in
the USA have passed mental health parity laws establishing
standards for reimbursement coverage of mental illness.8
South Africa is a country with a past record of discrimination.
However, while the apartheid era was universally condemned as
one of the worst examples of human rights violations, the
transition to democracy and the accompanying constitution
stipulating equality for all before the law offers a message of
hope. Unfortunately many South Africans can attest to the fact
that a liberal constitution does not necessarily imply freedom
from discrimination. Psychiatrists have long held that there is
widespread discrimination against the mentally ill in South
Africa. In the past few years, various support and advocacy
groups, as well as the South African Society of Psychiatrists, have
issued a plethora of press releases highlighting discriminatory
practices against the mentally ill. However, there has been little
research published on this subject, particularly in the South
African context.
In order to investigate this issue empirically, we evaluated the
benefits available for two common disorders in South Africa, one
a so-called ‘psychiatric disorder’ and one a ‘physical disorder’.
We chose major depressive disorder (MDD) and ischaemic heart
disease (IHD), as these are both common disorders in South
Africa.9-11 Further, a landmark World Health Report12 identified
both of these disorders as major contributors to the worldwide
burden of disease in terms of death and disability-adjusted life
years. In this report, MDD is identified as the fourth most
important cause of disability in the world and IHD as the sixth
most important. The purpose of this study was to compare
benefits available for MDD and IHD to persons with private
health insurance in South Africa.
What was done
This was a descriptive study of benefits offered by private medical
funds open to all members of the public in South Africa. Only
information available in the public domain was used and we
limited our search to medical funds where information could be
obtained from a website. Only options with a monthly premium
above R450 were included. All information included refers to
single members only. Medical fund options were excluded from
the study if they did not have a website that was accessible
without a password. Options that offer only a savings plan or
hospital plan were also not included. The study protocol was
approved by the institutional review board of the University of
Stellenbosch. 
One hundred and sixty-four South African medical funds were
identified using the Internet search engine ‘ananzi’. Each medical
fund was then contacted telephonically to obtain a web address.
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Information obtained from the website concerning inpatient care,
outpatient care, specialist consultations, psychotherapy and
chronic medications was entered into a Statistica database. All
information was gathered over a 5-month period stretching from
November 2002 to March 2003.
Statistical analysis 
Statistical analysis was performed using Statistica 6 software
(StatSoft, Inc. 1999 - 2003). The majority of the analyses were
discriptive in nature. Where means were calculated, standard
deviations (in brackets) and ranges are presented. Correlations
between numerical variables were calculated using Spearman’s
rank order correlation coefficients.
What was found
Of the 164 funds identified, 57 fulfilled the criteria for inclusion in
this study. Funds excluded and reasons for doing so are listed in
Table I. The remaining 57 funds offered 130 different options that
were included in the analysis. The mean monthly premium for the
130 options was R994.80 (SD R370.80) per member per month.
Benefits provided for inpatient and outpatient treatment for the
two disorders are presented in Table II. These amounts only
include options where limits had been placed on benefits.  When
we considered options with no limits placed on benefits, we found
that there were 96 options (73.8% of the total) with no limits placed
on inpatient benefits for the treatment of IHD, but only 11 options
(8.5% of the total) with no limits placed on inpatient treatment for
MDD. We did not find a statistically significant correlation
between the monthly premium paid by members and inpatient
benefits for either IHD (r = 0.15, t = 0.79, p = 0.43) or MDD (r =
0.07, t = 0.80, p = 0.43).
In terms of outpatient benefits, 10 options (7.7% of the total)
offered unlimited benefits for the treatment of IHD whereas 3
options (2.3% of the total) offered unlimited benefits for MDD.
When correlations were sought between monthly premiums and
outpatient benefits, we found that although there was a trend
towards such an association for IHD, this did not reach statistical
significance (r = 0.17, t = 1.90, p = 0.06). In the case of outpatient
treatment for MDD, a significant correlation was found between
the monthly premium and benefits for psychiatry (r = 0.20, t = 2.19,
p = 0.03) and psychology (r = 0.26, t = 2.93, p = 0.004).
Although our information on chronic benefits was somewhat
limited, we found that in the majority of options (115/130,
representing 88.5% of the total) chronic medication benefits for the
two disorders were the same. The benefits for IHD were
considered to be better than for MDD in 12 of the options. In 4 of
these, limits were placed on the amounts available for psychiatric
disorders that were not placed on the treatment of IHD; in 4 other
options there were co-payments for prescriptions for psychiatric
medications that did not apply to IHD; and in a further 4 options
chronic medications for the treatment of psychiatric disorders
required prior motivation by a specialist whereas chronic benefits
for the treatment of IHD received automatic authorisation. Two
options (1.5% of the total) offered no chronic benefits for either
disorder. There were no instances where chronic benefits offered
for MDD were considered more favourable than those for IHD. We
did not find any significant differences in the premiums between
options with greater benefits for IHD and those with equal benefits
(t = 0.12, df = 119, p = 0.91).
Discussion 
Notwithstanding the fact that the global disease burden of MDD is
greater than that of IHD, there is, at our most conservative
estimate, a 20-fold greater benefit availability for the inpatient
treatment of IHD than for the treatment of MDD in private health
care settings in South Africa. In fact, the vast majority of the
options that we considered placed no limitations on the inpatient
treatment of IHD whereas in most cases there were severe
Table I.  Medical funds excluded from the analysis
Reason for exclusion Number of funds
Closed schemes — not open to the public 59
No telephone number available 26
No website 7
Insufficient information on website 11
Only offering hospital plan 1
Only offering savings plan 1
No longer in existence 1
Fund liquidated 1
Total 107
Table II. Inpatient and outpatient benefits for IHD and MDD
Mean (Rands) Minimum (Rands) Maximum (Rands) Standard deviation (Rands)
Inpatient IHD* 411 509.09 10 000.00 2 000 000.00 440 091.29
Inpatient MDD* 20 283.19 0.00 300 000.00 35 196.32
Outpatient IHD 1 755.71 0.00 9 600.00 2 024.08
Outpatient MDD 850.17 0.00 7 500.00 1 365.60
Psychology 736.85 0.00 3 000.00 803.64
* These figures include only capped options (IHD = 33 and MDD = 118) and exclude options with no limits.
IHD = ischaemic heart disease; MDD = major depressive disorder.
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restrictions placed on the treatment of MDD. Although this was
the most prominent discrepancy, outpatient benefits and even
chronic medication benefits showed discriminatory funding
policies, albeit not to the same degree.
Another sobering finding was that the outpatient benefits for
psychiatry or psychology do not cover more than three sessions
per year with either of these professions — a visit frequency that
is hopelessly inadequate to provide a reasonable standard of
care. In fact, the data on outpatient benefits suggest that, in
South Africa, most medical fund options offer little beyond a
hospital plan. Although most people with mental illness can
attest to discrimination on a variety of levels,13 it is so much
more disconcerting when this occurs within the health care
industry.
There will no doubt be defenders of the current approach of
differentiating psychiatric disorders from other medical illness
in terms of service provision, possibly arguing that psychiatric
patients are less ill, or less likely to benefit from treatment
interventions. This is simply not true, however, as the disability
caused by MDD in terms of impaired physical and role
functioning, more days in bed due to illness, more work days
lost, increased impairment at work, and high use of health
services is greater than for most other diseases.14,15 Furthermore,
modern psychiatry is able to provide extensive evidence for
effective intervention in MDD and other psychiatric disorders.16
Ironically, depression is a co-morbid disorder in up to 25% of
patients with IHD and has also been identified as an important
independent risk factor for cardiac events after coronary artery
bypass surgery.17,18 Clearly, restricting funding for the treatment
of MDD is not only discriminatory, but also shortsighted as
effective intervention is likely to be cost saving when taking
into account the total direct and indirect costs of treating
MDD.19
Psychiatrists frequently encounter obstacles to the admission
of their patients to private hospitals.  While stigmatisation and
negative stereotypes probably contribute to this, there may be
another reason for this problem — the fee structure for
inpatient treatment of psychiatric patients is different from that
of patients with other disorders, with the daily tariff for a
psychiatric bed often only about 50% of that of a general
medical bed. Hospital financial managers, eager to balance
budgets and maximise profits, may therefore be less eager to
have psychiatric patients in their hospitals. Another risk of
discriminating against psychiatric patients and reimbursement
of psychiatrists and other health care workers is that working
conditions become increasingly difficult, and rewards fewer.
This is likely to be a substantial contributory factor to the
current mass exodus of psychiatrists and other mental health
care workers from South Africa.  According to the South
African Society of Psychiatrists, almost 40% of all practising
psychiatrists  in the country have left over the past 2 years!
The Bill of Rights of the Republic of South Africa20 specifies
people with disability as one of the groups that may not be
discriminated against. It goes on to state that ‘National
legislation must be enacted to prevent or prohibit unfair
discrimination.’  Psychiatric disorders are included among
these disabilities. Section 10(1) of the recently approved Mental
Health Care Act of South Africa21 states: ‘A mental health care
user may not be unfairly discriminated against on the grounds
of his or her mental health status.’ Despite these legal
safeguards, discriminatory practices continue unabated. 
A limiting factor in interpreting the results of this study may
be the fact that we did not present standardised cost models for
the two disorders. Future studies should preferably incorporate
some sense of the cost of ‘standard practice’ and ‘best practice’
to further ensure fairness in the comparison. However, the
magnitude of the difference in benefits as well as the fact that
there are time limits placed on psychiatric treatment only,
should convince even the most jaded sceptic. Discrimination by
the health industry against the mentally ill is a fact. Health
professionals, in conjunction with consumer advocacy groups,
should address this issue without delay.
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